U.S. Tech Hardware Stock News

NYSE:EPR
NYSE:EPRSpecialized REITs

Is It Too Late To Consider EPR Properties (EPR) After Its Recent Share Price Run?

Wondering if EPR Properties at about US$56.56 is still offering value after its recent run, or if most of the easy gains are already behind it. The stock shows returns of 0.9% over 7 days, 12.1% over 30 days, 11.4% year to date, 22.1% over 1 year, 72.7% over 3 years, and 66.0% over 5 years, which provides useful context before weighing up what the current price might imply. Recent coverage around EPR Properties has focused on its role within the Specialized REITs space and investor interest...
NYSE:FCX
NYSE:FCXMetals and Mining

Is Freeport McMoRan (FCX) Still Attractive After Its 100% One Year Share Price Surge

Wondering if Freeport-McMoRan at around US$67.57 is still priced for opportunity or if most of the value is already on the table? This article walks through what the current market price might be implying. The stock has had a mixed short term path, with a 1% decline over the last 7 days, a 29.7% gain over 30 days, a 30.1% gain year to date, and a 100.7% return over the past year. These moves sit against a backdrop of ongoing investor interest in large US listed materials companies and...
NasdaqGM:FLY
NasdaqGM:FLYAerospace & Defense

Assessing Firefly Aerospace (FLY) Valuation After Strong Recent Share Price Momentum

What Firefly Aerospace’s recent performance means for stock watchers Firefly Aerospace (FLY) has drawn attention after a recent share move, with the stock up about 81% over the past month and roughly 46% over the past 3 months. This has prompted closer scrutiny from investors. See our latest analysis for Firefly Aerospace. The recent surge in Firefly Aerospace’s 30 day share price return of 81.3% and 90 day share price return of 45.6% sits alongside a year to date share price return of 77.2%...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Core Scientific (CORZ) Is Up 11.2% After $3.3 Billion AI Debt Deal - What's Changed

In April 2026, Core Scientific Finance I LLC completed a US$3.30 billion senior secured notes offering due 2031, issued at 100%, with guarantees and call features under Regulation S and Rule 144A to refinance debt and fund new AI-focused data centers. This large speculative-grade bond issue underpins Core Scientific’s shift from primarily Bitcoin mining toward AI infrastructure and high-performance computing under a long-term CoreWeave agreement. Next, we’ll examine how funding...
NYSE:ROL
NYSE:ROLCommercial Services

Assessing Rollins (ROL) Valuation After FTC Order Halting Noncompete Agreements

The Federal Trade Commission has ordered Rollins (ROL) to stop enforcing noncompete agreements affecting more than 18,000 employees. This move raises fresh questions about labor flexibility, competition, and regulatory risk around the stock. See our latest analysis for Rollins. At a share price of US$54.71, Rollins has seen a 2.72% 1 month share price return but a 13.57% 3 month share price decline. Its 5 year total shareholder return of 62.31% contrasts with a slightly negative 1 year total...
NYSE:DEI
NYSE:DEIOffice REITs

Is Douglas Emmett (DEI) Quietly Redefining Its Earnings Mix With Beverly Hills Medical Offices?

Earlier this month, Douglas Emmett, Inc. acquired the Bedford Collection, a 246,000-square-foot, 95% leased outpatient medical portfolio in Beverly Hills’ Golden Triangle for US$260 million via a joint venture financed with a US$130 million, interest-only loan maturing in 2031 at SOFR plus 1.70%. This deal means Douglas Emmett now controls roughly one third of both the Golden Triangle’s medical office space and Beverly Hills’ Class A office inventory, concentrating high-value healthcare...
NYSE:VG
NYSE:VGOil and Gas

A Look At Venture Global (VG) Valuation After Recent Share Price Volatility

Recent performance snapshot Venture Global (VG) has drawn fresh attention after a sharp move in its share price, with the stock up about 4.6% over the past day and showing mixed returns across recent periods. See our latest analysis for Venture Global. That 5.6% 1 day share price return sits against a weaker 30 day share price return of a 23.5% decline, while the 90 day share price return of 33.6% and 1 year total shareholder return of 41.5% point to momentum building over a longer...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Credo Buys DustPhotonics To Target AI Data Center Optics Growth

Credo Technology Group Holding (NasdaqGS:CRDO) has agreed to acquire optical interconnect company DustPhotonics for US$750 million. The deal is aimed at building a more vertically integrated optical stack and expanding Credo's silicon photonics capabilities. This acquisition is intended to help Credo participate more directly in AI data center build outs as demand shifts from copper to optical connectivity. Credo Technology Group focuses on connectivity solutions for data centers, with a...
NYSE:CL
NYSE:CLHousehold Products

A Look At Colgate-Palmolive (CL) Valuation As Governance And Leadership Changes Draw Focus

Proxy fight spotlight on Colgate-Palmolive stock Colgate-Palmolive (CL) has moved into the governance spotlight after urging shareholders to reject proposals on board diversity criteria and an independent chair ahead of its May 8, 2026 annual meeting. See our latest analysis for Colgate-Palmolive. Governance tensions around the May 2026 meeting come as Colgate-Palmolive’s share price sits at $81.81, with recent 1 month and 3 month share price returns modestly negative, while the 3 year and 5...
NYSE:MMS
NYSE:MMSProfessional Services

Assessing Maximus (MMS) Valuation After A 31% Three Month Share Price Decline

Why Maximus is on investors’ radar today Maximus (MMS), a US based provider of government services, is drawing fresh attention after a period of weaker share performance, including a roughly 31% decline over the past 3 months. See our latest analysis for Maximus. That 31% 3 month share price decline stands out against a roughly flat 1 year total shareholder return of 1.22%. This suggests recent momentum has faded even though longer term holders have largely held their ground. If Maximus’s...
NYSE:MAIR
NYSE:MAIRBuilding

Cramer Spotlight Puts Madison Air IPO Rollup Valuation In Focus

Jim Cramer highlighted Madison Air Solutions (NYSE:MAIR) shortly after its IPO, calling attention to the company on national financial media. Cramer pointed to Madison Air's rollup activity and acquisitions as key parts of its story. The stock most recently closed at $33.8, with a reported year to date return of 6.5%. For investors tracking newly listed names, NYSE:MAIR is now on the radar after its high profile IPO and Cramer endorsement. With a share price of $33.8 and a 6.5% return year...
NasdaqGS:WWD
NasdaqGS:WWDAerospace & Defense

A Look At Woodward (WWD) Valuation After Pilot Controls Sale To Ontic

Woodward’s pilot controls sale reshapes aerospace exposure Woodward (WWD) has agreed to sell its pilot controls product line and related services to Ontic Engineering and Manufacturing, including throttle quadrants, rudder pedals, and passive side sticks produced in Niles, Illinois. The deal includes customary closing conditions and regulatory approvals, as well as a long term supply agreement that keeps Woodward as the sole supplier of certain electromechanical components, and 9 to 12 months...
NasdaqGM:SHLS
NasdaqGM:SHLSElectrical

A Look At Shoals Technologies Group (SHLS) Valuation After Mixed Earnings And Ongoing Profitability Concerns

Shoals Technologies Group (SHLS) is back in focus after reporting 38.6% year on year revenue growth that topped expectations by 2.4%. The company paired upbeat next quarter guidance with full year EBITDA guidance that fell short. See our latest analysis for Shoals Technologies Group. The mixed earnings message appears to have cooled enthusiasm in the near term, with a 1 day share price return of a 3.0% decline and a 7 day share price return of a 4.9% decline. However, the 1 month share price...
NYSE:WRB
NYSE:WRBInsurance

Is It Time To Reassess W. R. Berkley (WRB) After Its Recent Share Price Pullback?

Investors may be wondering whether W. R. Berkley at around US$65 a share still offers value, or if most of the opportunity has already been priced in. The stock has declined 0.9% over the past week and is down 5.7% year to date, following a 105.7% gain over the past 5 years. Recent coverage has focused on W. R. Berkley as a well known name in insurance, with investors watching how it positions itself against peers and broader sector trends. That backdrop helps explain why short term moves...
NYSE:CXW
NYSE:CXWCommercial Services

Does CoreCivic’s New Short‑Term Loan Signal a Shift in Its Balance Sheet Strategy (CXW)?

On April 10, 2026, CoreCivic, Inc. entered into a Second Amendment to its Fourth Amended and Restated Credit Agreement, adding a US$100 million incremental term loan to its US$800 million credit facility, largely to repay revolver borrowings and support working capital and general corporate needs. The prepayable, 364-day incremental term loan, priced 25 basis points above the company’s existing term and revolving debt, adjusts CoreCivic’s funding mix and short-term liquidity profile without...
NYSE:GEL
NYSE:GELOil and Gas

What Genesis Energy (GEL)'s Payout and Revenue Beat Reveal About Its Gulf of Mexico Strategy

Genesis Energy, L.P. previously declared quarterly cash distributions for the March 31, 2026 quarter, setting payments of US$0.18 per common unit and US$0.9473 per Class A Convertible Preferred unit, payable on May 15, 2026 to holders of record as of April 30, 2026. The announcement comes alongside revenue that exceeded analyst expectations, supported by strong offshore pipeline volumes and improved marine transportation utilization, underscoring the importance of its Gulf of Mexico...
NYSE:ARES
NYSE:ARESCapital Markets

Is It Too Late To Consider Ares Management (ARES) After Its Recent Share Price Rebound?

If you are asking whether Ares Management at around US$119.84 still offers value after a strong multi year run, this article walks through what the current price really implies. The stock has seen a 6.4% move over the last week and 13.2% over the last month, set against a year to date return of a 28.0% decline and a 12.6% decline over the past year, while the 3 year and 5 year returns sit at 57.2% and 150.0% respectively. Recent coverage has focused on how Ares Management is positioned...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Is Duolingo (DUOL) Now Attractively Priced After A 69.5% One Year Share Price Slide

This article examines whether Duolingo, trading at around US$102.63, might represent a bargain or remain priced for perfection, and what the current share price may be implying about the company’s value. The stock has moved 12.2% over the last 7 days and 4.7% over the last 30 days, while the year to date return reflects a 41.8% decline and the 1 year return a 69.5% decline. Recent headlines around Duolingo have focused on its position as a leading language learning platform, its ongoing...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Assessing Radware (RDWR) Valuation After Recent Share Price Momentum

Radware (RDWR) has been drawing fresh attention after recent share price moves, with the stock up over the past week, month and past 3 months as investors reassess this cyber security and application delivery provider. See our latest analysis for Radware. The recent 4.61% 1 day share price return and 11.58% 7 day share price return sit alongside a 12.62% year to date share price return. At the same time, the 1 year total shareholder return of 27.04% and 3 year total shareholder return of...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Why Marvell Technology (MRVL) Is Up 13.1% After Reported Google Custom AI Chip Talks

Recently, reports indicated that Alphabet’s Google is in talks with Marvell Technology to co-develop two custom AI chips, a memory processing unit and a next-generation tensor processing unit for inference workloads, which would deepen Marvell’s role inside a major cloud provider’s infrastructure stack. This prospective collaboration highlights how hyperscalers may increasingly lean on Marvell’s custom silicon expertise alongside its existing ecosystem ties, potentially reinforcing its...
NYSE:DCO
NYSE:DCOAerospace & Defense

Is It Too Late To Consider Ducommun (DCO) After A 158% One Year Rally?

Investors may be wondering whether Ducommun, at its recent close of around US$141.48, still offers value or whether most of the opportunity is already reflected in the price. The stock has posted returns of 0.1% over the last week, 17.3% over the last month, 46.2% year to date and 157.6% over the past year, with 3 year and 5 year returns of 179.1% and 143.9% respectively. Recent coverage has focused on Ducommun's role within the capital goods sector and investor interest in companies exposed...
NYSE:GS
NYSE:GSCapital Markets

Will Strong Q1 Earnings, Fed Order Lift and Buybacks Change Goldman Sachs Group's (GS) Narrative?

In recent weeks, The Goldman Sachs Group, Inc. has reported first‑quarter 2026 net income of US$5,630 million and completed multiple fixed and floating rate bond offerings across US dollar, euro and sterling markets, alongside confirming a quarterly dividend of US$4.50 per share. Together with the termination of a 2018 Federal Reserve cease‑and‑desist order and an accelerated US$5,000 million buyback tranche, these actions highlight Goldman’s focus on capital strength, funding flexibility...
NYSE:CI
NYSE:CIHealthcare

Maryland Action On Cigna Automation Puts Claims Practices And Valuation In Focus

Maryland Insurance Administration issues enforcement action against Cigna Group (NYSE:CI) over automatic downcoding of evaluation and management claims. Regulator orders Cigna to stop the automated practice and imposes a fine related to its use in Maryland. Decision highlights closer scrutiny of insurer billing systems and potential implications for similar processes in other states. Cigna Group, through its health insurance operations, sits at the center of how medical claims are processed...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

A Look At Immunome (IMNM) Valuation As Shares Trade Near US$23.85 After Strong One Year Return

Immunome stock performance context Immunome (IMNM) has drawn investor interest after recent trading left the stock at a last close of US$23.85, with performance figures that show mixed returns over different time frames. Over the past week, the share price return is about 4.1%, while the past month shows roughly 19.2%. By contrast, the past 3 months reflect a return of about a 4.1% decline, and the 1 year total return is about 191.2%. See our latest analysis for Immunome. Recent trading shows...